Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

285
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
285
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Preclinical Development: Overview01:28

Preclinical Development: Overview

6.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

556
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
556
The Scientific Method in Nursing Process01:18

The Scientific Method in Nursing Process

19.3K
The scientific method provides the foundation for any research. It is the most reliable and objective of all forms of gaining knowledge and guides in applying research-based evidence in practice and conducting future research.
When using research findings to change practice, one must understand the process used to guide a study. The scientific method is a systematic, step-by-step process that supports the data's validity, reliability, and generalizability. As a result, findings can be...
19.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Observance of antifibrotic treatment in the French OPALE support program for patients with pulmonary fibrosis].

Revue des maladies respiratoires·2026
Same author

Adequacy of anticoagulation in patients with nonvalvular atrial fibrillation.

Journal of healthcare quality research·2026
Same author

Eczema following IL-5 inhibitors for the treatment of severe asthma with improvement after switching to an IL-4Rα mAb.

The journal of allergy and clinical immunology. In practice·2025
Same author

[Use of fluticasone/umeclidinium/vilanterol in France: A population based study].

Revue des maladies respiratoires·2025
Same author

Testicular lodges creation during scrotal reconstruction by ALT (anterolateral thigh) island flap after Fournier gangrene: A case report.

Annales de chirurgie plastique et esthetique·2025
Same author

A Psychometric Evaluation of the Body Image Questionnaire Child and Adolescent Version.

Child psychiatry and human development·2024

Related Experiment Video

Updated: Apr 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.6K

[COLIBRI: Improving clinical practice and producing relevant scientific data].

E Kelkel1, F Herengt2, H Ben Saidane3

  • 1Service de pneumologie, centre hospitalier de Chambéry, 73000 Chambéry, France.

Revue Des Maladies Respiratoires
|July 12, 2015
PubMed
Summary
This summary is machine-generated.

The COLIBRI-COPD portal collects real-world data on chronic obstructive pulmonary disease (COPD) patients. Initial findings reveal significant patient variability within GOLD stages, highlighting the need for personalized COPD management.

Keywords:
BPCOBase de donnéesCOPDDatabaseNavigateur InternetObservational studyPhenotypePhénotypeWeb browserÉtude observationnelle

More Related Videos

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
09:43

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Published on: November 22, 2019

6.9K
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.9K

Related Experiment Videos

Last Updated: Apr 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.6K
Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
09:43

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Published on: November 22, 2019

6.9K
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.9K

Area of Science:

  • Pulmonology
  • Digital Health
  • Real-World Data

Background:

  • Chronic obstructive pulmonary disease (COPD) management requires comprehensive patient data.
  • Existing data collection methods may not capture the full spectrum of COPD phenotypes.
  • A francophone web portal, COLIBRI-COPD, was developed for pulmonologists.

Purpose of the Study:

  • To describe the phenotype of COPD patients entered into the COLIBRI-COPD database.
  • To assess the completeness and reliability of real-world data collected via a web portal.
  • To identify variability in patient characteristics and management within established COPD severity stages.

Main Methods:

  • Prospective data collection of 1079 COPD patients via the COLIBRI-COPD web portal.
  • Phenotypic data included anthropometry, exposures, functional impairments, and validated questionnaires (MRC, CAT, HAD, etc.).
  • Analysis of data completeness, reliability, and comparison of patient characteristics across GOLD stages.

Main Results:

  • High completeness for key data items in the initial 1079 patients.
  • Significant variability observed among patients with the same GOLD stage in exacerbation incidence, anxiety-depression, diabetes, and medication prescriptions.
  • Data quality is influenced by web tool usability and practitioner self-assessment.

Conclusions:

  • Real-world data collection through the COLIBRI-COPD portal provides a reliable database for longitudinal COPD research.
  • Significant patient heterogeneity exists even within the same GOLD stage, underscoring the need for individualized treatment strategies.
  • The usability of the web tool is crucial for ensuring data quality and facilitating practitioner engagement.